Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 11/20 | 0.67 |
| ▸ | EGFR | P00533 | 3/20 | 0.53 |
| ▸ | INSR | P06213 | 2/20 | 0.53 |
| ▸ | MET | P08581 | 2/20 | 0.53 |
| ▸ | CDK2 | P24941 | 2/20 | 0.53 |
| ▸ | KDR | P35968 | 2/20 | 0.53 |
| ▸ | TEK | Q02763 | 2/20 | 0.53 |
| ▸ | AURKA | O14965 | 3/20 | 0.50 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.50 |
| ▸ | EPHB4 | P54760 | 2/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6319818 | 0.78 | IGF1R (0.67) | IGF1REGFRINSRMETCDK2 | |
| SCHEMBL6318996 | 0.78 | IGF1R (0.67) | IGF1REGFRINSRMETCDK2 | |
| SCHEMBL6312556 | 0.76 | IGF1R (0.69) | IGF1REGFRINSRMETCDK2 | |
| SCHEMBL30023065 | 0.76 | SYK (0.49) | CDK2AURKATNNI3KSYK | |
| SCHEMBL6320480 | 0.76 | IGF1R (0.69) | IGF1REGFRINSRMETCDK2 | |
| SCHEMBL6642791 | 0.76 | IGF1R (0.71) | IGF1REGFRINSRMETCDK2 | |
| SCHEMBL6319730 | 0.76 | IGF1R (0.71) | IGF1REGFRINSRMETCDK2 | |
| SCHEMBL14634689 | 0.75 | TNNI3K (0.52) | AURKATNNI3KEPHB4SYK | |
| SCHEMBL6311161 | 0.75 | IGF1R (0.66) | IGF1REGFRINSRMETCDK2 | |
| SCHEMBL6641667 | 0.73 | JAK3 (0.65) | IGF1RKDRAURKATNNI3KEPHB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6939874-B2 | Substituted pyrimidinyl derivatives and methods of use | AMGEN INC. (US) | 2005-09-06 | — | — | US | disclosed |